With regard to South Korea, Novartis solved particular well-publicized allegations that it had made incorrect payments to HCPs in South Korea as a result of round tables and 3rd-social gathering clinical journals. Novartis Korea allegedly transmitted poor honoraria to HCPs for round tables as a result of health-related journals to prevent complianc